Table 2. Blood Pressure Change Among MTM Patients (N = 298), by Hypertension Stage, Mississippi Delta Health Collaborative, 2009–2018a .
| Baseline | No. of Patients Showing Decrease in BP, No. (%)b | Change in BP Between Baseline and Follow-Up |
|||||
|---|---|---|---|---|---|---|---|
| BP type | Baseline Mean, mm Hg | Post-MTM Mean, mm Hg | Change, mm Hg | P Valuec | Relative % Reduction |
||
| At Risk (n = 137) | 93 (68) | Systolic | 128.9 | 129.0 | 0.1 | .92 | — |
| Diastolic | 79.3 | 77.5 | –1.8 | .03 | 2.3 | ||
| Stage I (n = 100) | 77 (77) | Systolic | 145.1 | 139.3 | –5.7 | .003 | 3.9 |
| Diastolic | 84.9 | 80.9 | –4.0 | <.001 | 4.7 | ||
| Stage II (n = 46) | 41 (89) | Systolic | 160.9 | 147.5 | –13.4 | <.001 | 8.3 |
| Diastolic | 92.2 | 85.1 | –7.1 | <.001 | 7.7 | ||
| Stage III and IV (n = 14) | 14 (100) | Systolic | 177.5 | 147.6 | –29.8 | .002 | 16.8 |
| Diastolic | 104.4 | 91.3 | –13.1 | .01 | 12.5 | ||
Abbreviations: —, not applicable; BP, blood pressure; MTM, medication therapy management.
a
Normal values at baseline were excluded. Second laboratory result was 6 to 9 months after first visit.
b
Decrease in either systolic or diastolic blood pressure.
c
P values determined by using paired t test.